JAMES RAPLEY: Open Payments
NPI 1235399973 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$41,393 in 94 payments from 8 companies in 2025. Trend: 2023 $10,876 · 2024 $44,848 · 2025 $41,393
Speaker / faculty: $35,300Travel & lodging: $3,373Food & beverage: $2,170Consulting: $550
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 74 | $40,971 |
| E.R. Squibb & Sons, L.L.C. | 9 | $187 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
| Alkermes, Inc. | 1 | $14 |
Products named: VRAYLAR, COBENFY, TRINTELLIX, REXULTI, SPRAVATO, ARISTADA.
Industry payments across VA — which companies pay providers there.
